123 related articles for article (PubMed ID: 7620835)
21. Ontogeny of food deprivation effects on ornithine decarboxylase: ornithine decarboxylase induction by alpha and beta agonists.
Kuhn CM; McMillian MK; Evoniuk GE; Schanberg SM
J Pharmacol Exp Ther; 1985 Nov; 235(2):361-7. PubMed ID: 2865350
[TBL] [Abstract][Full Text] [Related]
22. Effect of captopril on isoproterenol-induced myocardial ornithine decarboxylase activity.
Shimizu M; Irimajiri O; Nakano T; Mizokami T; Ogawa K; Sanjo J; Yamada H; Sasaki H; Isogai Y
J Mol Cell Cardiol; 1991 Jun; 23(6):665-70. PubMed ID: 1719221
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.
Delisée C; Schaeffer P; Cazaubon C; Chatelain P
Eur J Pharmacol; 1993 Oct; 247(2):139-44. PubMed ID: 8282003
[TBL] [Abstract][Full Text] [Related]
25. Role of thyroid hormone in the development of beta adrenergic control of ornithine decarboxylase in rat heart and kidney.
Pracyk JB; Lappi SE; Slotkin TA
J Pharmacol Exp Ther; 1991 Feb; 256(2):757-66. PubMed ID: 1847210
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
Dostal DE; Baker KM
Am J Hypertens; 1992 May; 5(5 Pt 1):276-80. PubMed ID: 1533768
[TBL] [Abstract][Full Text] [Related]
27. The cardiac renin-angiotensin system in STZ-induced diabetes.
Sechi LA; Griffin CA; Schambelan M
Diabetes; 1994 Oct; 43(10):1180-4. PubMed ID: 7926285
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.
Fujimura A; Sudoh T; Ebihara A
Life Sci; 1994; 55(9):707-11. PubMed ID: 8065233
[TBL] [Abstract][Full Text] [Related]
29. Regional changes in ornithine decarboxylase activity and polyamine levels during thyroxine-induced cardiac hypertrophy.
Tipnis UR; Skiera C
Cytobios; 1989; 57(229):101-8. PubMed ID: 2528442
[TBL] [Abstract][Full Text] [Related]
30. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats.
Fregly MJ; Rowland NE
Proc Soc Exp Biol Med; 1992 Feb; 199(2):158-64. PubMed ID: 1311103
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of oxidized glutathione on heart ornithine decarboxylase activity.
Guarnieri C; Rossoni Caldarera C; Muscari C; Flamigni F; Caldarera CM
Ital J Biochem; 1982; 31(6):404-11. PubMed ID: 7184904
[TBL] [Abstract][Full Text] [Related]
32. Prenatal ethanol alters development of cardiac ornithine decarboxylase response to adrenergic agents in rat. I. Continuous exposure.
Thadani PV
Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):192-202. PubMed ID: 6360060
[TBL] [Abstract][Full Text] [Related]
33. Load-induced growth responses in isolated adult rat hearts. Role of the AT1 receptor.
Thienelt CD; Weinberg EO; Bartunek J; Lorell BH
Circulation; 1997 Jun; 95(12):2677-83. PubMed ID: 9193437
[TBL] [Abstract][Full Text] [Related]
34. Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adults rats.
Bareis DL; Slotkin TA
J Pharmacol Exp Ther; 1978 Apr; 205(1):164-74. PubMed ID: 633081
[TBL] [Abstract][Full Text] [Related]
35. AT1 receptors and cell proliferation in rat adrenals: effects of angiotensin infusion, low sodium diet and losartan.
McEwan PE; Vinson GP; Kenyon CJ
Endocr Res; 1996 Nov; 22(4):369-71. PubMed ID: 8969885
[No Abstract] [Full Text] [Related]
36. The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures.
Stuhr LE; Maehle BO
Scand J Clin Lab Invest; 1997 May; 57(3):253-61. PubMed ID: 9238761
[TBL] [Abstract][Full Text] [Related]
37. Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.
Batenburg WW; van Esch JH; Garrelds IM; Jorde U; Lamers JM; Dekkers DH; Walther T; Kellett E; Milligan G; van Kats JP; Danser AH
J Hypertens; 2006 Jul; 24(7):1355-63. PubMed ID: 16794485
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy.
Mackintosh CA; Feith DJ; Shantz LM; Pegg AE
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):645-53. PubMed ID: 10970775
[TBL] [Abstract][Full Text] [Related]
39. Chronic Losartan treatment blocks isoproterenol-induced dipsogenesis.
Iyer SN; Wright BE; Strubbe G; Hanley K; Katovich MJ
Physiol Behav; 1995 Aug; 58(2):283-6. PubMed ID: 7568431
[TBL] [Abstract][Full Text] [Related]
40. Distribution of Fos in rat brain resulting from endogenously-generated angiotensin II.
Oldfield BJ; McKinley MJ
Kidney Int; 1994 Dec; 46(6):1567-9. PubMed ID: 7700008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
